• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Liver Cancer-Results From the Global Burden of Disease Study 2021.

作者信息

Liu Chunlong, He Ziqiang, Yu Jiangtao, Yang Rui

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Fuyang People's Hospital, Fuyang, China.

Department of Hepato-Biliary-Pancreatic Surgery, Fuyang Fifth People's Hospital of Anhui Province, Fuyang, China.

出版信息

Aliment Pharmacol Ther. 2025 Mar;61(6):1077-1079. doi: 10.1111/apt.18510. Epub 2025 Jan 23.

DOI:10.1111/apt.18510
PMID:39853570
Abstract
摘要

相似文献

1
Letter: Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Liver Cancer-Results From the Global Burden of Disease Study 2021.
Aliment Pharmacol Ther. 2025 Mar;61(6):1077-1079. doi: 10.1111/apt.18510. Epub 2025 Jan 23.
2
Letter: Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Liver Cancer-Results From the Global Burden of Disease Study 2021. Authors' Reply.信函：代谢功能障碍相关脂肪性肝病相关肝癌的全球负担——来自《2021年全球疾病负担研究》的结果。作者回复
Aliment Pharmacol Ther. 2025 Mar;61(6):1080-1081. doi: 10.1111/apt.18520. Epub 2025 Jan 23.
3
Liver cancer in 2021: Global Burden of Disease study.2021年肝癌：全球疾病负担研究
J Hepatol. 2025 May;82(5):851-860. doi: 10.1016/j.jhep.2024.10.031. Epub 2024 Oct 30.
4
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' Perspective.应对代谢功能障碍相关脂肪性肝病（MASLD）和代谢功能障碍相关脂肪性肝炎（MASH）日益加重的全球负担：从患病率上升到支付方视角
Aliment Pharmacol Ther. 2025 May;61(9):1467-1478. doi: 10.1111/apt.70020. Epub 2025 Feb 18.
5
Global Trends and Inequalities of Liver Complications Related to Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis From 1990 to 2021.与代谢功能障碍相关脂肪性肝病相关肝脏并发症的全球趋势及不平等现象：1990年至2021年的分析
Liver Int. 2025 Apr;45(4):e16120. doi: 10.1111/liv.16120. Epub 2024 Oct 10.
6
Letter to the editor: global burden of metabolic dysfunction-associated steatotic liver disease: results from the global burden of disease study 2021.致编辑的信：代谢功能障碍相关脂肪性肝病的全球负担：2021年全球疾病负担研究结果
Metabolism. 2025 Jan;162:156055. doi: 10.1016/j.metabol.2024.156055. Epub 2024 Nov 1.
7
Menopause and metabolic dysfunction-associated steatotic liver disease.绝经与代谢功能紊乱相关的脂肪性肝病。
Maturitas. 2024 Aug;186:108024. doi: 10.1016/j.maturitas.2024.108024. Epub 2024 May 14.
8
Global burden of metabolic dysfunction-associated steatotic liver disease attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2021.204 个国家和地区 1990 年至 2021 年归因于空腹血糖升高的代谢功能障碍相关脂肪性肝病的全球负担。
Sci Rep. 2024 Sep 27;14(1):22232. doi: 10.1038/s41598-024-72795-0.
9
Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.代谢相关脂肪性肝病在三级中心炎症性肠病中的患病率及相关危险因素。
Rev Assoc Med Bras (1992). 2024 Jul 19;70(6):e20231321. doi: 10.1590/1806-9282.20231321. eCollection 2024.
10
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021.2010年至2021年代谢功能障碍相关脂肪性肝病的全球负担
JHEP Rep. 2024 Nov 14;7(3):101271. doi: 10.1016/j.jhepr.2024.101271. eCollection 2025 Mar.

引用本文的文献

1
Letter: Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Liver Cancer-Results From the Global Burden of Disease Study 2021. Authors' Reply.信函：代谢功能障碍相关脂肪性肝病相关肝癌的全球负担——来自《2021年全球疾病负担研究》的结果。作者回复
Aliment Pharmacol Ther. 2025 Mar;61(6):1080-1081. doi: 10.1111/apt.18520. Epub 2025 Jan 23.